Stuart Walter Peltz is CHIEF EXECUTIVE OFFICER of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 166,962 shares of PTCT, which is worth approximately $6.66 Million. The most recent transaction as insider was on Jan 31, 2023, when has been sold 2,320 shares (Common Stock) at a price of $45.63 per share, resulting in proceeds of $105,861. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 167K
0% 3M change
0% 12M change
Total Value Held $6.66 Million

Stuart Walter Peltz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2023
SELL
Open market or private sale
$105,861 $45.63 p/Share
2,320 Reduced 1.37%
166,962 Common Stock
Jan 11 2023
SELL
Open market or private sale
$52,744 $44.36 p/Share
1,189 Reduced 0.7%
169,282 Common Stock
Jan 10 2023
SELL
Open market or private sale
$52,718 $42.93 p/Share
1,228 Reduced 0.72%
170,471 Common Stock
Jan 09 2023
SELL
Open market or private sale
$74,404 $41.66 p/Share
1,786 Reduced 1.03%
171,699 Common Stock
Jan 05 2023
BUY
Grant, award, or other acquisition
-
53,000 Added 23.4%
173,485 Common Stock
Feb 01 2022
SELL
Open market or private sale
$78,440 $40.0 p/Share
1,961 Reduced 1.6%
120,485 Common Stock
Jan 07 2022
SELL
Open market or private sale
$71,994 $38.52 p/Share
1,869 Reduced 2.33%
78,446 Common Stock
Jan 07 2022
BUY
Grant, award, or other acquisition
-
44,000 Added 26.43%
122,446 Common Stock
Feb 01 2021
SELL
Open market or private sale
$112,097 $56.96 p/Share
1,968 Reduced 2.39%
80,315 Common Stock
Jan 06 2021
BUY
Grant, award, or other acquisition
-
27,600 Added 25.12%
82,283 Common Stock
Jan 05 2021
SELL
Open market or private sale
$87,443 $62.37 p/Share
1,402 Reduced 2.5%
54,683 Common Stock
Dec 30 2020
SELL
Open market or private sale
$17,805,946 $62.32 p/Share
285,718 Reduced 83.59%
56,085 Common Stock
Dec 30 2020
BUY
Exercise of conversion of derivative security
$9,125,833 $31.94 p/Share
285,718 Added 62.42%
172,022 Common Stock
Dec 07 2020
SELL
Open market or private sale
$1,245,057 $62.2 p/Share
20,017 Reduced 26.3%
56,085 Common Stock
Dec 07 2020
SELL
Open market or private sale
$21,803,936 $62.58 p/Share
348,417 Reduced 86.13%
56,085 Common Stock
Dec 07 2020
BUY
Exercise of conversion of derivative security
$298,253 $14.9 p/Share
20,017 Added 24.03%
63,293 Common Stock
Dec 07 2020
BUY
Exercise of conversion of derivative security
$6,536,303 $18.76 p/Share
348,417 Added 64.28%
193,585 Common Stock
Nov 02 2020
SELL
Open market or private sale
$2,696,500 $53.93 p/Share
50,000 Reduced 47.13%
56,085 Common Stock
Nov 02 2020
BUY
Exercise of conversion of derivative security
$542,500 $10.85 p/Share
50,000 Added 32.03%
106,085 Common Stock
Oct 07 2020
SELL
Open market or private sale
$3,790,554 $53.31 p/Share
71,104 Reduced 55.9%
56,085 Common Stock
Oct 07 2020
BUY
Exercise of conversion of derivative security
$784,988 $11.04 p/Share
71,104 Added 40.55%
104,260 Common Stock
Oct 06 2020
SELL
Open market or private sale
$6,233,716 $50.13 p/Share
124,351 Reduced 68.92%
56,085 Common Stock
Oct 06 2020
BUY
Exercise of conversion of derivative security
$1,365,374 $10.98 p/Share
124,351 Added 53.54%
107,910 Common Stock
Oct 05 2020
SELL
Open market or private sale
$2,773,000 $50.0 p/Share
55,460 Reduced 49.72%
56,085 Common Stock
Oct 05 2020
BUY
Exercise of conversion of derivative security
$601,741 $10.85 p/Share
55,460 Added 33.39%
110,645 Common Stock
SWP

Stuart Walter Peltz

CHIEF EXECUTIVE OFFICER
South Plainfield, NJ

Track Institutional and Insider Activities on PTCT

Follow PTC THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

News

Receive news related to PTC THERAPEUTICS, INC.

Track Activities on PTCT